| ALKEM LABORATORIES  | 
ALKEM LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity - Authorised | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | 
| Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | 
| Equity Shares Forfeited | - | - | - | - | - | 
| Adjustments to Equity | - | - | - | - | - | 
| Preference Capital Paid Up | - | - | - | - | - | 
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | 
| Share Warrants & Outstandings | ₹36 Cr | ₹20 Cr | ₹0.60 Cr | ₹0.60 Cr | ₹1.12 Cr | 
| Total Reserves | ₹11,925 Cr | ₹10,269 Cr | ₹9,021 Cr | ₹8,613 Cr | ₹7,352 Cr | 
| Securities Premium | - | - | - | - | - | 
| Capital Reserves | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr | 
| Profit & Loss Account Balance | ₹9,973 Cr | ₹8,310 Cr | ₹7,052 Cr | ₹6,594 Cr | ₹5,367 Cr | 
| General Reserves | ₹1,987 Cr | ₹1,987 Cr | ₹1,987 Cr | ₹1,987 Cr | ₹1,987 Cr | 
| Other Reserves | ₹-36 Cr | ₹-29 Cr | ₹-19 Cr | ₹32 Cr | ₹-2.82 Cr | 
| Reserve excluding Revaluation Reserve | ₹11,925 Cr | ₹10,269 Cr | ₹9,021 Cr | ₹8,613 Cr | ₹7,352 Cr | 
| Revaluation reserve | - | - | - | - | - | 
| Shareholder's Funds | ₹11,985 Cr | ₹10,312 Cr | ₹9,045 Cr | ₹8,638 Cr | ₹7,377 Cr | 
| Minority Interest | ₹449 Cr | ₹402 Cr | ₹390 Cr | ₹209 Cr | ₹181 Cr | 
| Long-Term Borrowings | - | - | - | - | - | 
| Secured Loans | ₹62 Cr | ₹40 Cr | - | ₹0.03 Cr | ₹18 Cr | 
| Non Convertible Debentures | - | - | - | - | - | 
| Converible Debentures & Bonds | - | - | - | - | - | 
| Packing Credit - Bank | - | - | - | - | - | 
| Inter Corporate & Security Deposit | - | - | - | - | - | 
| Term Loans - Banks | - | - | - | - | ₹18 Cr | 
| Term Loans - Institutions | ₹62 Cr | ₹40 Cr | - | ₹0.03 Cr | ₹0.16 Cr | 
| Other Secured | - | - | - | - | - | 
| Unsecured Loans | ₹248 Cr | - | - | ₹9.35 Cr | ₹9.46 Cr | 
| Fixed Deposits - Public | - | - | - | - | - | 
| Loans and advances from subsidiaries | - | - | - | - | - | 
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - | 
| Foreign Currency Convertible Notes | - | - | - | - | - | 
| Long Term Loan in Foreign Currency | ₹248 Cr | - | - | - | - | 
| Loans - Banks | - | - | - | - | - | 
| Loans - Govt. | - | - | - | - | - | 
| Loans - Others | - | - | - | ₹9.35 Cr | ₹9.46 Cr | 
| Other Unsecured Loan | - | - | - | - | - | 
| Deferred Tax Assets / Liabilities | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr | ₹-1,108 Cr | 
| Deferred Tax Assets | ₹1,971 Cr | ₹1,770 Cr | ₹1,498 Cr | ₹1,528 Cr | ₹1,282 Cr | 
| Deferred Tax Liability | ₹233 Cr | ₹256 Cr | ₹196 Cr | ₹219 Cr | ₹174 Cr | 
| Other Long Term Liabilities | ₹643 Cr | ₹526 Cr | ₹245 Cr | ₹74 Cr | ₹79 Cr | 
| Long Term Trade Payables | - | - | - | - | - | 
| Long Term Provisions | ₹338 Cr | ₹300 Cr | ₹369 Cr | ₹333 Cr | ₹251 Cr | 
| Total Non-Current Liabilities | ₹-446 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr | ₹-751 Cr | 
| Current Liabilities | - | - | - | - | - | 
| Trade Payables | ₹1,839 Cr | ₹1,748 Cr | ₹1,165 Cr | ₹1,173 Cr | ₹1,069 Cr | 
| Sundry Creditors | ₹1,839 Cr | ₹1,748 Cr | ₹1,165 Cr | ₹1,173 Cr | ₹1,069 Cr | 
| Acceptances | - | - | - | - | - | 
| Due to Subsidiaries- Trade Payables | - | - | - | - | - | 
| Other Current Liabilities | ₹1,164 Cr | ₹892 Cr | ₹839 Cr | ₹771 Cr | ₹643 Cr | 
| Bank Overdraft / Short term credit | - | - | - | - | - | 
| Advances received from customers | ₹220 Cr | ₹112 Cr | ₹74 Cr | ₹73 Cr | ₹40 Cr | 
| Interest Accrued But Not Due | - | - | - | ₹0.20 Cr | ₹0.09 Cr | 
| Share Application Money | - | - | - | - | - | 
| Current maturity of Debentures & Bonds | - | - | - | - | - | 
| Current maturity - Others | - | - | - | - | - | 
| Other Liabilities | ₹944 Cr | ₹780 Cr | ₹765 Cr | ₹698 Cr | ₹603 Cr | 
| Short Term Borrowings | ₹735 Cr | ₹1,173 Cr | ₹1,307 Cr | ₹2,571 Cr | ₹1,636 Cr | 
| Secured ST Loans repayable on Demands | ₹424 Cr | ₹387 Cr | ₹301 Cr | ₹1,335 Cr | ₹631 Cr | 
| Working Capital Loans- Sec | ₹424 Cr | ₹387 Cr | ₹301 Cr | ₹1,335 Cr | ₹631 Cr | 
| Buyers Credits - Unsec | - | - | - | - | - | 
| Commercial Borrowings- Unsec | - | - | - | - | - | 
| Other Unsecured Loans | ₹-114 Cr | ₹398 Cr | ₹706 Cr | ₹-100 Cr | ₹374 Cr | 
| Short Term Provisions | ₹220 Cr | ₹182 Cr | ₹396 Cr | ₹290 Cr | ₹256 Cr | 
| Proposed Equity Dividend | - | - | - | - | - | 
| Provision for Corporate Dividend Tax | - | - | - | - | - | 
| Provision for Tax | ₹61 Cr | ₹55 Cr | ₹23 Cr | ₹16 Cr | ₹19 Cr | 
| Provision for post retirement benefits | - | - | - | - | - | 
| Preference Dividend | - | - | - | - | - | 
| Other Provisions | ₹159 Cr | ₹127 Cr | ₹373 Cr | ₹274 Cr | ₹237 Cr | 
| Total Current Liabilities | ₹3,959 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr | 
| Total Liabilities | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr | ₹10,411 Cr | 
| ASSETS | |||||
| Gross Block | ₹4,720 Cr | ₹4,544 Cr | ₹4,050 Cr | ₹4,186 Cr | ₹3,723 Cr | 
| Less: Accumulated Depreciation | ₹1,867 Cr | ₹1,671 Cr | ₹1,367 Cr | ₹1,284 Cr | ₹930 Cr | 
| Less: Impairment of Assets | - | - | - | - | - | 
| Net Block | ₹2,852 Cr | ₹2,873 Cr | ₹2,683 Cr | ₹2,902 Cr | ₹2,793 Cr | 
| Lease Adjustment A/c | - | - | - | - | - | 
| Capital Work in Progress | ₹477 Cr | ₹148 Cr | ₹310 Cr | ₹339 Cr | ₹393 Cr | 
| Non Current Investments | ₹943 Cr | ₹335 Cr | ₹305 Cr | ₹232 Cr | ₹154 Cr | 
| Long Term Investment | ₹943 Cr | ₹335 Cr | ₹305 Cr | ₹232 Cr | ₹154 Cr | 
| Quoted | ₹710 Cr | ₹170 Cr | ₹143 Cr | ₹105 Cr | ₹56 Cr | 
| Unquoted | ₹233 Cr | ₹164 Cr | ₹162 Cr | ₹127 Cr | ₹98 Cr | 
| Long Term Loans & Advances | ₹508 Cr | ₹204 Cr | ₹139 Cr | ₹154 Cr | ₹94 Cr | 
| Other Non Current Assets | ₹155 Cr | ₹79 Cr | ₹275 Cr | ₹697 Cr | ₹49 Cr | 
| Total Non-Current Assets | ₹5,007 Cr | ₹3,648 Cr | ₹3,724 Cr | ₹4,325 Cr | ₹3,483 Cr | 
| Current Assets Loans & Advances | - | - | - | - | - | 
| Currents Investments | ₹902 Cr | ₹149 Cr | ₹317 Cr | ₹139 Cr | ₹179 Cr | 
| Quoted | ₹828 Cr | ₹47 Cr | ₹212 Cr | ₹31 Cr | ₹34 Cr | 
| Unquoted | ₹75 Cr | ₹102 Cr | ₹122 Cr | ₹124 Cr | ₹145 Cr | 
| Inventories | ₹2,922 Cr | ₹2,661 Cr | ₹2,608 Cr | ₹3,006 Cr | ₹2,312 Cr | 
| Raw Materials | ₹927 Cr | ₹869 Cr | ₹806 Cr | ₹790 Cr | ₹662 Cr | 
| Work-in Progress | ₹129 Cr | ₹147 Cr | ₹164 Cr | ₹134 Cr | ₹109 Cr | 
| Finished Goods | ₹1,114 Cr | ₹829 Cr | ₹1,008 Cr | ₹1,344 Cr | ₹913 Cr | 
| Packing Materials | - | - | - | - | - | 
| Stores  and Spare | - | - | - | - | - | 
| Other Inventory | ₹753 Cr | ₹816 Cr | ₹629 Cr | ₹737 Cr | ₹628 Cr | 
| Sundry Debtors | ₹2,466 Cr | ₹2,253 Cr | ₹2,132 Cr | ₹1,885 Cr | ₹1,607 Cr | 
| Debtors more than Six months | ₹111 Cr | ₹213 Cr | ₹107 Cr | ₹95 Cr | ₹99 Cr | 
| Debtors Others | ₹2,435 Cr | ₹2,132 Cr | ₹2,069 Cr | ₹1,836 Cr | ₹1,560 Cr | 
| Cash and Bank | ₹1,563 Cr | ₹1,579 Cr | ₹2,617 Cr | ₹2,579 Cr | ₹1,990 Cr | 
| Cash in hand | ₹1.17 Cr | ₹1.04 Cr | ₹0.76 Cr | ₹0.72 Cr | ₹0.52 Cr | 
| Balances at Bank | ₹1,493 Cr | ₹1,569 Cr | ₹2,613 Cr | ₹2,516 Cr | ₹1,986 Cr | 
| Other cash and bank balances | ₹69 Cr | ₹9.70 Cr | ₹2.82 Cr | ₹62 Cr | ₹3.84 Cr | 
| Other Current Assets | ₹156 Cr | ₹237 Cr | ₹245 Cr | ₹240 Cr | ₹330 Cr | 
| Interest accrued on Investments | - | - | ₹90 Cr | ₹57 Cr | ₹40 Cr | 
| Interest accrued on Debentures | - | - | - | - | - | 
| Deposits with Government | - | - | - | - | - | 
| Interest accrued and or due on loans | - | - | - | - | - | 
| Prepaid Expenses | ₹60 Cr | ₹50 Cr | ₹44 Cr | ₹56 Cr | ₹30 Cr | 
| Other current_assets | ₹97 Cr | ₹187 Cr | ₹110 Cr | ₹127 Cr | ₹260 Cr | 
| Short Term Loans and Advances | ₹2,801 Cr | ₹3,532 Cr | ₹688 Cr | ₹586 Cr | ₹505 Cr | 
| Advances recoverable in cash or in kind | ₹211 Cr | ₹192 Cr | ₹146 Cr | ₹74 Cr | ₹32 Cr | 
| Advance income tax and TDS | - | - | - | - | - | 
| Amounts due from directors | - | - | - | - | - | 
| Due From Subsidiaries | - | - | - | - | - | 
| Inter corporate deposits | - | - | - | - | - | 
| Corporate Deposits | - | - | - | - | - | 
| Other Loans & Advances | ₹2,590 Cr | ₹3,340 Cr | ₹542 Cr | ₹512 Cr | ₹473 Cr | 
| Total Current Assets | ₹10,811 Cr | ₹10,412 Cr | ₹8,606 Cr | ₹8,434 Cr | ₹6,923 Cr | 
| Net Current Assets (Including Current Investments) | ₹6,853 Cr | ₹6,417 Cr | ₹4,899 Cr | ₹3,628 Cr | ₹3,319 Cr | 
| Miscellaneous Expenses not written off | - | - | - | - | - | 
| Total Assets | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr | ₹10,411 Cr | 
| Contingent Liabilities | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr | 
| Total Debt | ₹1,063 Cr | ₹1,214 Cr | ₹1,307 Cr | ₹2,580 Cr | ₹1,701 Cr | 
| Book Value | 999.47 | 860.94 | 756.56 | 722.48 | 616.95 | 
| Adjusted Book Value | 999.47 | 860.94 | 756.56 | 722.48 | 616.95 | 
Compare Balance Sheet of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹65,863.7 Cr | 0.7% | 1.6% | -8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| ALKEM LABORATORIES | 0.7% | 1.6% | -8.4% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    